Table 3.

Unadjusted means by treatment condition and between group effect sizes for all time points

		CBI		SI
Measurea	Time	Mean	SD	Mean	SD	d b
STAXI‐2 AX	Baseline	55.67	12.98	54.77	11.86	0.07
	Week 4	49.16	15.30	52.88	12.82	−0.11
	Week 8	40.33	17.95	49.61	13.89	−0.48
	End of TX	37.50	16.68	46.00	13.64	−0.39
	Month 3	40.31	14.07	43.81	13.85	−0.22
	Month 6	42.06	15.27	44.61	14.20	−0.21
OASM AGGc	Baseline	1.335	0.525	1.396	0.500	−0.12
	Week 4	1.234	0.486	1.285	0.541	−0.02
	Week 8	0.953	0.639	1.148	0.638	−0.16
	End of TX	0.909	0.608	1.103	0.662	−0.19
	Month 3	0.908	0.448	1.024	0.728	−0.06
	Month 6	0.946	0.758	1.117	0.549	−0.23
OQ total	Baseline	82.73	27.04	89.71	22.59	−0.28
	End of TX	60.96	29.37	72.04	25.70	−0.24
	Month 3	56.76	28.19	76.55	26.64	−0.57
	Month 6	61.17	28.82	70.71	27.60	−0.50
LIFE Social	Baseline	3.57	0.54	3.64	0.71	−0.11
	End of TX	2.92	0.64	3.38	0.78	−0.53
	Month 3	2.95	0.78	3.27	0.78	−0.39
	Month 6	2.79	0.79	3.06	0.92	−0.38
LIFE occupation	Baseline	3.17	1.22	2.98	1.08	0.16
	End of TX	2.88	0.88	3.21	1.07	−0.38
	Month 3	3.05	0.85	3.00	0.95	−0.20
	Month 6	2.84	0.90	2.71	0.97	−0.09
WHO QOL psychological	Baseline	11.54	3.17	10.97	2.61	0.20
	End of TX	14.11	2.50	11.70	3.26	0.61
	Month 3	13.92	2.32	11.39	3.30	0.43
	Month 6	13.59	2.73	12.24	2.98	0.17
CAPS severity	Baseline	30.02	10.62	32.38	9.52	−0.21
	End of TX	22.40	11.99	24.24	10.58	−0.08
	Month 3	22.37	12.73	24.93	12.54	−0.16
	Month 6	21.89	11.58	23.38	12.41	−0.23

Abbreviations: CAPS, Clinician Rated PTSD Scale; LIFE, Longitudinal Interval Follow‐up Evaluation; OAS‐M AGG, Overt Aggression Scale Modified, Aggression Score; STAXI‐2 AX, State‐Trait Anger Inventory, Anger Index; TX, Treatment; WHO QOL, World Health Organization Quality of Life.

^a For most measures, a higher score indicates higher severity/poorer functioning. Exceptions: WHO QOL.

^b Negative effect size indicates larger effect for CBI, except for WHO QOLwhere positive effect size indicates larger effect for CBI.

^c OAS‐M scores are log10 transformed.